OBES REV
| WoS 期刊 JCR 分区 (2026 · JIF) | 综合 SCIE | Q1 | ||
|---|---|---|---|---|
| 学科 | 收录集 | JIF 分区 | JIF 排名 | JIF 百分位 |
| 内分泌学与代谢 Endocrinology & Metabolism | SCIE | Q1 | 19/198 |
90.4%
|
| 学科 | 收录集 | JCI 分区 | JCI 排名 | JCI 百分位 |
|---|---|---|---|---|
| 内分泌学与代谢 Endocrinology & Metabolism | SCIE | Q1 | 18/161 JCI 1.54 |
89.4%
|
Obesity Reviews, published under the ISSN 1467-7881 and abbreviated as OBES REV, is a premier international journal dedicated to the comprehensive study of obesity. As the official journal of the World Obesity Federation, its scope encompasses all aspects of the obesity epidemic, including its epidemiology, etiology, pathogenesis, treatment, prevention, and public health policy. The journal prioritizes high-quality, authoritative review articles, including systematic reviews and meta-analyses, that synthesize current knowledge and highlight emerging trends in the field. It also publishes original research, commentaries, and special supplements that address critical issues such as metabolic complications, bariatric surgery, behavioral interventions, and the social determinants of obesity. The target audience is broad, comprising clinical researchers, endocrinologists, nutritionists, epidemiologists, public health professionals, and policymakers working to combat obesity on a global scale. A notable feature of the journal is its strong commitment to open access, with many articles published under a Creative Commons license, ensuring wide dissemination of findings. Published by Wiley on behalf of the World Obesity Federation, Obesity Reviews maintains an exceptional standing in the field, evidenced by its 2026 Impact Factor of 7.6000 and its placement in the Q1 quartile of the JCR. This high impact factor firmly establishes it as a leading, essential resource for evidence-based insights into the complex and multifaceted challenge of obesity.